Evidence map›Paper›PMID 29474122›Full record

ReviewCritical reviews in toxicology2018

Non-animal methods to predict skin sensitization (II): an assessment of defined approaches

Nicole C Kleinstreuer, Sebastian Hoffmann, Nathalie Alépée, David Allen, Takao Ashikaga, Warren Casey, Elodie Clouet, Magalie Cluzel, Bertrand Desprez, Nichola Gellatly and 11 more

Abstract readReview
In one paragraph

Review in Critical reviews in toxicology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Frontiers in toxicology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Nicole C Kleinstreuera NIH/NIEHS/DNTP/NICEATM , Research Triangle Park , NC , USA.
Sebastian Hoffmannb SEH Consulting + Services , Paderborn , Germany.
Nathalie Alépéec L'Oréal Research & Innovation , Aulnay-sous-Bois , France.
David Allend ILS , Research Triangle Park , NC , USA.
Takao Ashikagae Shiseido , Yokohama-shi , Kanagawa , Japan.
Warren Caseya NIH/NIEHS/DNTP/NICEATM , Research Triangle Park , NC , USA.
Elodie Clouetf Pierre Fabre , Toulouse , France.
Magalie Cluzelg LVMH , St Jean de Braye , France.
Bertrand Desprezh Cosmetics Europe , Brussels , Belgium.
Nichola Gellatlyi Unilever , London , UK.
Carsten Göbelj Coty , Darmstadt , Germany.
Petra S Kernk Procter & Gamble Services Company NV , Strombeek-Bever , Belgium.
Martina Klarich Cosmetics Europe , Brussels , Belgium.
Jochen Kühnll Beiersdorf AG , Hamburg , Germany.
Silvia Martinozzi-Teissierc L'Oréal Research & Innovation , Aulnay-sous-Bois , France.
Karsten Mewesm Henkel AG & Co. KGaA , Düsseldorf , Germany.
Masaaki Miyazawan Kao Corporation , Haga , Tochigi , Japan.
Judy Stricklandd ILS , Research Triangle Park , NC , USA.
Erwin van Vlieto Services & Consultations on Alternative Methods (SeCAM) , Magliaso , Switzerland.
Qingda Zangd ILS , Research Triangle Park , NC , USA.
Dirk Petersohnm Henkel AG & Co. KGaA , Düsseldorf , Germany.

Funding

Biomolecular Screening and Alternative Approaches for the National Toxicology ProgramZIAES103318 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI CASEY, WARREN · 2016 to 2021
$25.0M
Intramural NIH HHS Z99 ES999999NIEHS NIH HHS HHSN273201500010C
6 · The paper itself

Abstract

Skin sensitization is a toxicity endpoint of widespread concern, for which the mechanistic understanding and concurrent necessity for non-animal testing approaches have evolved to a critical juncture, with many available options for predicting sensitization without using animals. Cosmetics Europe and the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods collaborated to analyze the performance of multiple non-animal data integration approaches for the skin sensitization safety assessment of cosmetics ingredients. The Cosmetics Europe Skin Tolerance Task Force (STTF) collected and generated data on 128 substances in multiple in vitro and in chemico skin sensitization assays selected based on a systematic assessment by the STTF. These assays, together with certain in silico predictions, are key components of various non-animal testing strategies that have been submitted to the Organization for Economic Cooperation and Development as case studies for skin sensitization. Curated murine local lymph node assay (LLNA) and human skin sensitization data were used to evaluate the performance of six defined approaches, comprising eight non-animal testing strategies, for both hazard and potency characterization. Defined approaches examined included consensus methods, artificial neural networks, support vector machine models, Bayesian networks, and decision trees, most of which were reproduced using open source software tools. Multiple non-animal testing strategies incorporating in vitro, in chemico, and in silico inputs demonstrated equivalent or superior performance to the LLNA when compared to both animal and human data for skin sensitization.

Indexed as

Computer SimulationAnimalsAnimal Testing AlternativesComputational BiologyCosmeticsDermatitis, Allergic ContactHumansMiceSkinCosmeticsadverse outcome pathwaydefined approacheshazard assessmenthuman reference dataintegrated testing strategyLLNA reference datanew approach methodologiespotency assessmentSkin sensitization

Identifiers

PMID29474122
PMCPMC7393691

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.